ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Columbia Seligman Global Technology Fund Class S

Columbia Seligman Global Technology Fund Class S (CSGAX)

0.00
0.00
(0.00%)
Closed January 30 3:00PM
0.00
0.00
( 0.00% )

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CSGAX Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000FU
40000000FU
120000000FU
260000000FU
520000000FU
1560000000FU
2600000000FU

CSGAX - Frequently Asked Questions (FAQ)

What is the current Columbia Seligman Global... share price?
The current share price of Columbia Seligman Global... is US$ 0.00
What is the 1 year trading range for Columbia Seligman Global... share price?
Columbia Seligman Global... has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMODAlpha Modus Holdings Inc
US$ 3.12
(102.60%)
14.46M
ATHEAlterity Therapeutics Limited
US$ 5.81
(99.66%)
9.19M
CFSBCFSB Bancorp Inc
US$ 12.00
(57.27%)
6
GDEVGDEV Inc
US$ 24.99
(56.29%)
1
TECXTectonic Therapeutic Inc
US$ 39.99
(55.48%)
580.13k
CLEUChina Liberal Education Holdings Ltd
US$ 1.01
(-86.97%)
14.55M
CRGXCARGO Therapeutics Inc
US$ 3.21
(-75.66%)
3.43M
RILYGB Riley Financial Inc
US$ 5.01
(-56.43%)
105
ECBKECB Bancorp Inc
US$ 8.01
(-41.49%)
5
FBLAFB Bancorp Inc
US$ 7.01
(-40.34%)
7
MGOLMGO Global Inc
US$ 0.133999
(31.76%)
55.12M
NAOVNanoVibronix Inc
US$ 0.5466
(42.53%)
36.91M
KZIAKazia Therapeutics Ltd
US$ 2.0898
(51.43%)
28.45M
SPGCSacks Parente Golf Inc
US$ 0.774
(31.19%)
26.11M
BNZIBanzai International Inc
US$ 2.40
(24.35%)
18.9M

Discussion

View Full Feed
Debunkinator Debunkinator 4 minutes ago
Makes you wonder😗
Fontalk
Partnership Opportunities
Credit Bureaus and Alternative Credit Scoring Providers
eSIM Wholesalers/Aggregators
Mobile Top-Up Providers
Digital Gift Card Wholesalers
Community Organizations
ASII
CherryTree1 CherryTree1 5 minutes ago
Sounds illegal . . . what reason would a BP and MM have to share information about a 3rd company other than collaborating to manipulate the share price of the 3rd party?
NWBO
ORCA ORCA 5 minutes ago
:)))ONCE BARB IS OUT WE ROCK.UNTIL THEN IT MAKES NO SENSE TO BUY HER SHARES HIGH
VPLM
valleybenedetto valleybenedetto 5 minutes ago
They will a big reverse..max. New rules state if they fall below 1.00 after RS they can't do another. Forces companies to max RS for price protection. 
TTOO
Zardiw Zardiw 5 minutes ago
People forget that the CIA/FBI/godernment is really PEOPLE....not some entity on it's own..........

Z
al44 al44 6 minutes ago
Trump’s Gambit on Federal Workers

Making an offer that many won’t refuse.

by Mark Angelides | Jan 30, 2025


When Donald Trump won the 2024 election, the media airwaves were suddenly infused with a raft of stories regarding the federal workers who w
Nebuchadnezzar Nebuchadnezzar 6 minutes ago
RITE here ;)

Dallas, Texas, January 7, 2024 –– MINERALRITETM Corporation (the “Company” or “RITE”) recently
executed a Binding Letter of Intent to acquire two subsidiaries from a formerly publicly traded company.
The two subsidiaries collectively hold four mineral asse
RITE
dcaf7 dcaf7 6 minutes ago
Data from same day dosing trial will be presented at ACCC 51st Annual Meeting & Cancer Center Business Summit on March 5, 2025. Title: Eflapegrastim, a Long-Acting GCSF, Administered the Same Day as Chemotherapy in Patients with Early-Stage Breast Cancer: Results from a Multicenter, Open-Label, Stud
ASRT
tw0122 tw0122 6 minutes ago
Averaged down to .98 flip back out $1.13 this round kept a few of the .92s for final flip
CLEU
lakers17 lakers17 6 minutes ago
OTTO has totally collapsed. Heading toward a rug or a come back? Just too many new tokens and AI ones these days,.
manibiotech manibiotech 6 minutes ago
You mean the same English " around the corner", " one yard line", "imminent"


NWBO
TechandBio TechandBio 6 minutes ago
Nothing has changed except the scarcity of $BTC

$BTC
BTC
x993231 x993231 6 minutes ago
CMO VP/GM Components Business Avanex May 2005 to December 2007

Oh check this out he moved to Bookham January 2008.

Avanex merged with Bookham and was renamed Oclaro

He rose through the ranks to become Oclaro's Chief strategy officer yup acquired by Lument
LWLG
Zardiw Zardiw 6 minutes ago
One of the ways God/Allah/Buddha talks to us is through other people.

Z
bluefish1 bluefish1 7 minutes ago
ITS IMPORTANT TO AVERAGE DOWN AT THESE PRICES

You're an investment advisor now? Suggesting where people should invest their money? I thought only people with a license could offer financial advice. Are you licensed?

Please stop. You're not qualified to tell people when
SRMX
D theG D theG 7 minutes ago
Thanks for sharing G! That's a true glowing review by actual users
VTSI
tedpeele tedpeele 7 minutes ago
X is pushing a buyout on a boring stock - trying to make it exciting.

Good luck with that. $1-4 range this year more likely and any buyout will be a WTF moment.

The tea leaves were all laid out for people in January 9th.

..
LWLG
Spuds McKenz66 Spuds McKenz66 7 minutes ago
tech will boom this year and into 2026 best bet , my wild card MLGO thousands to be made here
MLGO
mouton29 mouton29 7 minutes ago
style="caret-color: rgb(45, 49, 63); color: rgba(45, 49, 63, 1); font-family: "Noto Sans JP", ????, sans-serif; background-color: rgba(255, 255, 255, 1)"I had not focused on the timing, that the treatment in a challenge study (or at least, the Shinogi study) is administered BEFORE the intentional in
ENTA
stocktowatch stocktowatch 7 minutes ago
$AIMD Huge News : Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation https://finance.yahoo.com/news/ainos-achieves-major-breakthrough-japan-150000331.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
@chazzsheen3
AIMD
Viking8084 Viking8084 7 minutes ago
Ok shorty...puffing your chest with no facts !!!
UMAV
surfkast surfkast 8 minutes ago
So you believe George will get this POS audited?
GVSI
10thMountain 10thMountain 8 minutes ago
Oh wow just seeing it. Let’s see if this helps to get it reversing
FDCT
TechandBio TechandBio 8 minutes ago
A market that could grow to $108.4 Billion globally by 2030. MASH 3.7 Billion Market cap. This is IV route drug. Looked in my Ira bought a chunk at $14.00 a few years ago.


AKRO
AKRO

Your Recent History

Delayed Upgrade Clock